Skip to main content
    A

    Ardelyx Inc (ARDX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.18
    +0.11 (+3.58%)

    Market Cap: $776.74M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Ardelyx Inc (ARDX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Ardelyx (ARDX) has a market cap of $776.74M and an enterprise value of $982.78M. Its share count is up 3.35% from a year earlier. It kept -11.85% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 26.53% above the market cap, as debt exceeds cash.

    Market Cap$776.74M
    Enterprise Value$982.78M
    Latest price (Nov 17, 2026)$3.18

    Key Dates

    Last Earnings DateNov 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.78% in the quarter ended Sep 30, 2026 and grew 2.94% a year over 2 years.

    Shares Outstanding250.01M
    Shares Change (YoY)+3.35%
    Shares Change (QoQ)+0.78%
    Share Count Growth (2Y CAGR)+2.94%

    Valuation Ratios

    Sales and book value multiples are 1.7x and 4.8x. Its year-end P/S ranged from 3.5x to 93.2x from 2017 to 2025.

    P/S Ratio1.7x
    Forward P/S1.6x
    P/B Ratio4.8x

    Valuation history and multiples

    Price Statistics

    The stock is down 45.73% over 52 weeks and trades 2.15% below its 50-day average.

    Beta (1Y)0.89
    52-Week Change-45.73%
    1-Month Change+2.91%
    3-Month Change-21.09%
    6-Month Change-47.78%
    5-Year Change+150.41%
    10-Year Change-75.37%
    Total Return (1Y)-45.73%
    Total Return (3Y CAGR)-9.78%
    Return vs SPY (1Y)-56.83%
    Max Drawdown (1Y)-63.95%
    Max Drawdown (3Y)-70.43%
    Sharpe Ratio (1Y)-1.04
    Correlation with SPY (1Y)0.21
    50-Day Average$3.25
    200-Day Average$5.06
    52-Week Range$2.80 to $8.40
    RSI (14 Days)52.0
    Average Volume (20 Days)4.76M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.45x current liabilities, and total debt is 1.54x shareholder equity.

    Current Ratio3.45x
    Quick Ratio3.26x
    Debt / Equity1.54x
    Interest Coverage-0.97x

    Returns and Efficiency

    Return on invested capital is -6.52% over the last 12 months, against a 5-year average of -29.20%.

    Return on Equity (ROE)-33.81%
    Return on Assets (ROA)-9.44%
    Return on Invested Capital (ROIC)-6.52%
    Return on Capital Employed (ROCE)-5.91%
    ROE (5Y Average)-71.78%
    ROA (5Y Average)-36.87%
    ROIC (5Y Average)-29.20%
    Asset Turnover0.87x
    Inventory Turnover1.03x
    Receivables Turnover4.83x
    Cash Conversion Cycle-78 days

    Scores

    ARDX has an Altman Z-Score of 0.02, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score0.02
    Altman Z ZoneDistress
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $468.22M over the last 12 months is up 17.57% from the 12 months before.

    Revenue$468.22M
    Revenue Growth (YoY)+17.57%
    Gross Profit$442.26M
    Operating Income-$36.10M
    Pretax Income-$55.26M
    Net Income-$55.47M
    EBITDA-$17.12M
    EBIT-$27.16M
    Reported EPS (TTM)-$0.23

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 27.92% of the $587.52M in total assets.

    Cash and Equivalents$46.32M
    Total Debt$252.36M
    Net Debt$206.04M
    Net Debt Per Share$0.82
    Working Capital$313.58M
    Shareholder Equity$164.05M
    Book Value Per Share$0.66
    Total Assets$587.52M
    Total Liabilities$423.48M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$15.51M
    FCF Per Share-$0.06
    Depreciation and Amortization$10.04M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -7.71%.

    Gross Margin94.46%
    Operating Margin-7.71%
    Pretax Margin-11.80%
    Net Margin-11.85%
    EBITDA Margin-3.66%
    EBIT Margin-5.80%
    Gross Margin (5Y Average)88.61%

    Growth

    Revenue grew 98.40% a year over 3 years.

    Revenue Growth (3Y CAGR)+98.40%
    Revenue Growth (5Y CAGR)+121.90%
    Book Value Per Share Growth (2Y CAGR)-5.08%
    Tangible Book Per Share Growth (2Y CAGR)-5.08%

    Revenue and profit by year

    Dividends and Yields

    ARDX does not pay a dividend.

    Buyback Yield-1.09%
    Shareholder Yield-1.09%

    Peer Position

    Against 8 similar companies, ARDX has the lowest P/S.

    P/S Ratio1.7x vs 7.6x median
    ROIC-6.52% vs -65.95% median
    Revenue Growth (Trailing 4 Quarters, YoY)+17.57% vs +15.80% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 22.18% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+22.18%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ARDX

    What is ARDX's market cap?

    Ardelyx has a market cap of $776.74M. Its enterprise value, which adds debt and subtracts cash, is $982.78M.

    How many shares of ARDX are outstanding?

    Ardelyx has 250.01M shares outstanding. The count is up 3.35% from a year earlier.

    Does ARDX pay a dividend?

    No. Ardelyx does not pay a dividend.

    How much debt does ARDX have?

    Ardelyx has $252.36M of total debt and $46.32M of cash and equivalents, a net debt position of $206.04M.